The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice.
AffiliationSection of Cell and Tumour Biology, Paterson Institute for Cancer Research, Manchester, United Kingdom. firstname.lastname@example.org
MetadataShow full item record
AbstractThis study set out to examine the effect of exogenous prostaglandin (PG) administration on tumor development in Min/+ mice. Mice were treated with the stable prostaglandin E2 analogue 16,16-dimethyl-PGE2 from 6-18 weeks of age. Mice were sacrificed, and tumor burden was assessed using morphometric techniques. Parameters measured were median tumor size, mean tumor size, the proportion of the area of the gastrointestinal mucosa covered with tumor, and the number of tumors per 1000 mm2 of gastrointestinal mucosa. In addition, proliferative and apoptotic indices were determined. These measurements were carried out for all regions of the small intestine (i.e., duodenum, jejunum, upper ileum, and lower ileum) and the large intestine (i.e., cecum and mid-colon/rectum). 16,16-Dimethyl-PGE2-treated animals showed a significant decrease in tumor burden (by approximately 50-70%), in comparison with those animals that were treated with vehicle alone (0.001% ethanol in 0.9% sterile saline), in all regions of the intestine (at P = 0.008 or better). This effect was contributed to by a reduction in the number of tumors (by approximately 20-50%) and a reduction in tumor size (by approximately 10-70%). An increase in tumor cell turnover was associated with this decrease in tumor burden, as determined by the changes in the levels of thymidine incorporation (significant at P = 0.003), apoptosis, and mitosis (nonsignificant).
CitationThe effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice. 2000, 60 (16):4645-53 Cancer Res.
- Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
- Authors: Hansen-Petrik MB, McEntee MF, Jull B, Shi H, Zemel MB, Whelan J
- Issue date: 2002 Jan 15
- Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) mice.
- Authors: Alferez D, Wilkinson RW, Watkins J, Poulsom R, Mandir N, Wedge SR, Pyrah IT, Smith NR, Jackson L, Ryan AJ, Goodlad RA
- Issue date: 2008 Mar
- Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
- Authors: Song J, Medline A, Mason JB, Gallinger S, Kim YI
- Issue date: 2000 Oct 1
- Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
- Authors: Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ
- Issue date: 2002 Apr 1